Top

Neurological Sciences

Published in:

01-03-2022 | Amyotrophic Lateral Sclerosis | Original Article

Validity and reliability of the Turkish version of “the Dyspnea-ALS-Scale (DALS-15)”

Authors: Esma Nur Kolbaşı, Ece Açıkbaş, Gamze Polen Akşimşek, Gökşen Kuran Aslan, Esen Kıyan

Published in: Neurological Sciences | Issue 3/2022

Abstract

Aim

The aim of this study was to investigate the validity and reliability of the Turkish version of The Dyspnea-ALS-Scale (DALS-15).

Methods

Forward translation, back translation, and cross-cultural adaptation were used to ensure the equivalency of translated version of the scale. Then, patients with amyotrophic lateral sclerosis (ALS) who have dyspnea or orthopnea that develops with effort or at rest were evaluated using DALS-15 via online surveys. The respiratory subscale of ALS Functional Rating Scale-Revised (ALSFRS-R) and Modified Borg Dyspnea Scale (MBDS) was used to investigate the construct validity of the Turkish DALS-15. Reliability was assessed with Cronbach’s α and inter-item correlation matrix (internal consistency).

Results

We have included 52 ALS patients in the study. Findings showed that Turkish version of DALS-15 was highly correlated with respiratory subscale of ALSFRS-R (r = − 0.668; p = < 0.0001) and MBDS (for upright position: r = 0.728; p = < 0.0001 and for supine: r = 0.78; p = < 0.0001). The scale did not show any ceiling or floor effect. Also, DALS-15 had a high level of Cronbach’s α (0.95) and internal consistency (ICC: 0.949; 95%CI: 0.92–0.96). Test-re-test reliability of the questionnaire was (ICC: 0.909; 95% CI: 0.81–0.95). The standard error of measurement value was 2.76, whereas the minimal detectable change score was 7.66 points for the translated version of the scale.

Conclusions

The Turkish version of DALS-15 possesses strong psychometric properties with excellent validity and reliability. It is shown to be useful for online self-assessment, outside of the clinical settings, especially in hard times such as a pandemic.

Available only for authorised users

Valadi N (2015) Evaluation and management of amyotrophic lateral sclerosis. Prim Care - Clin Off Pract 42:177–187. https://doi.org/10.1016/j.pop.2015.01.009CrossRef

Kamel F, Umbach DM, Stallone L et al (2008) Association of lead exposure with survival in amyotrophic lateral sclerosis. Environ Health Perspect 116:943–947. https://doi.org/10.1289/ehp.11193CrossRefPubMedPubMedCentral

Özcan F, Kaya A, Yayla ME (2016) Amyotrofik Lateral Skleroz Hastalığı ve Aile Hekiminin Rolü. Celal Bayar Üniv Sağlık Bilim Enstit Derg 3:431–435

Özoğuz A, Uyan Ö, Birdal G et al (2015) The distinct genetic pattern of ALS in Turkey and novel mutations. Neurobiol Aging 36:1764.e9-1764.e18. https://doi.org/10.1016/j.neurobiolaging.2014.12.032CrossRef

Vogt S, Petri S, Dengler R et al (2018) Dyspnea in amyotrophic lateral sclerosis (ALS): Rasch-based development and validation of a patient-reported outcome (DALS-15). J Pain Symptom Manag 56(5):736–745. https://doi.org/10.1016/j.jpainsymman.2018.08.009CrossRef

Vender R, Mauger D, Walsh S et al (2007) Respiratory systems abnormalities and clinical milestones for patients with amyotrophic lateral sclorosiswith emphasis upon survival. Amyotroph Lateral Scler 8:36–41. https://doi.org/10.1080/17482960600863951CrossRefPubMed

Prell T, Ringer TM, Wullenkord K et al (2016) Assessment of pulmonary function in amyotrophic lateral sclerosis: when can polygraphy help evaluate the need for non-invasive ventilation? J Neurol Neurosurg Psychiatry 87:1022–1026. https://doi.org/10.1136/jnnp-2015-312185CrossRefPubMed

Pihtili A, Bingol Z, Durmus H et al (2021) Diaphragmatic dysfunction at the first visit to a chest diseases outpatient clinic in 500 patients with amyotrophic lateral sclerosis. Muscle Nerve 63(5):683–689. https://doi.org/10.1002/mus.27200CrossRefPubMed

Tanaka K, Akechi T, Okuyama T et al (2000) Development and validation of the Cancer Dyspnoea Scale: a multidimensional, brief, self-rating scale. Br J Cancer 82:800–805. https://doi.org/10.1054/bjoc.1999.1002CrossRefPubMedPubMedCentral

10.

Windisch W, Freidel K, Schucher B et al (2003) The Severe Respiratory Insufficiency (SRI) Questionnaire A specific measure of health-related quality of life in patients receiving home mechanical ventilation. J Clin Epidemiol 56:752–759. https://doi.org/10.1016/S0895-4356(03)00088-XCrossRefPubMed

11.

Vogt S, Schreiber S, Kollewe K et al (2019) Dyspnea in amyotrophic lateral sclerosis: The Dyspnea-ALS-Scale (DALS-15) essentially contributes to the diagnosis of respiratory impairment. Respir Med 154:116–121. https://doi.org/10.1016/j.rmed.2019.06.014CrossRefPubMed

12.

Vogt S, Schreiber S, Heinze H-J et al (2019) The Dyspnea-ALS-Scale (DALS-15) optimizes individual treatment in patients with amyotrophic lateral sclerosis (ALS) suffering from dyspnea. Health Qual Life Outcomes 17:95. https://doi.org/10.1186/s12955-019-1167-0CrossRefPubMedPubMedCentral

13.

Beaton DE, Bombardier C, Guillemin F, Ferraz MB (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 25:3186–3191. https://doi.org/10.1097/00007632-200012150-00014

14.

Koc F, Balal M, Demir T et al (2016) Adaptation to Turkish and reliability study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R). Noro Psikiyatr Ars 53:229–233. https://doi.org/10.5152/npa.2016.11334CrossRefPubMedPubMedCentral

15.

Kara D YH (2013) Dispne Semptomunun Değerlendirilmesinde Dispne Ölçeklerinin Etkinlikleri Ve Kullanım Sıklıkları. Gümüşhane Üniversitesi Sağlık Bilim Derg 2(1):137–149. Retrieved from https://dergipark.org.tr/tr/pub/gumussagbil/issue/7505/98941

16.

Ries AL (2005) Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD J Chronic Obstr Pulm Dis 2:105–110. https://doi.org/10.1081/COPD-200050655CrossRef

17.

Maier A, Holm T, Wicks P et al (2012) Online assessment of ALS functional rating scale compares well to in-clinic evaluation: a prospective trial. Amyotroph Lateral Scler 13:210–216. https://doi.org/10.3109/17482968.2011.633268CrossRefPubMedPubMedCentral

18.

Meyer R, Spittel S, Steinfurth L, Funke A, Kettemann D, Münch C, Meyer T, Maier A (2018) Patient-reported outcome of physical therapy in amyotrophic lateral sclerosis: Observational online study. JMIR Rehabilitation and Assistive Technologies 5(2):e10099. https://doi.org/10.2196/10099

19.

Anthoine E, Moret L, Regnault A et al (2014) Sample size used to validate a scale: a review of publications on newly-developed patient reported outcomes measures. Health Qual Life Outcomes 12:176. https://doi.org/10.1186/s12955-014-0176-2CrossRefPubMed

20.

Akoglu H (2018) User’s guide to correlation coefficients. Turkish J Emerg Med 18(3):91–93. https://doi.org/10.1016/j.tjem.2018.08.001CrossRef

21.

Nunnally J, Bernstein I (1994) Psychometric Theory, 3rd edn. McGraw-Hill, New York

22.

Terwee CB, Bot SDM, de Boer MR et al (2007) Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. https://doi.org/10.1016/j.jclinepi.2006.03.012CrossRefPubMed

23.

Ries JD, Echternach JL, Nof L, Blodgett MG (2009) Test-retest reliability and minimal detectable change scores for the timed “up & go” test, the six-minute walk test, and gait speed in people with Alzheimer disease. Phys Ther. https://doi.org/10.2522/ptj.20080258CrossRefPubMed

24.

Özdemir O (2006) Correlation analysis. In: Özdemir O (ed) Medical Statistics. İstanbul Medikal Yayıncılık, Istanbul, pp 213–225

Title: Validity and reliability of the Turkish version of “the Dyspnea-ALS-Scale (DALS-15)”
Authors: Esma Nur Kolbaşı
Ece Açıkbaş
Gamze Polen Akşimşek
Gökşen Kuran Aslan
Esen Kıyan
Publication date: 01-03-2022
Publisher: Springer International Publishing
Keywords: Amyotrophic Lateral Sclerosis
Dyspnea
Dyspnea
Published in: Neurological Sciences / Issue 3/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-021-05516-4

At a glance: The STEP trials

Springer Medicine

Validity and reliability of the Turkish version of “the Dyspnea-ALS-Scale (DALS-15)”

Abstract

Aim

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Aim

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 3/2022

Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19

Development of magnetic resonance imaging of brachial plexus neuralgia

The reliability and validity of the Turkish version of the Telemedicine Satisfaction and Usefulness Questionnaire (TSUQ) and Telemedicine Patient Questionnaire (TPQ) in individuals with multiple sclerosis

Progressive supranuclear palsy with marked ventricular dilatation mimicking normal pressure hydrocephalus

The effects of concurrent M1 anodal tDCS and physical therapy interventions on function of ankle muscles in patients with stroke: a randomized, double-blinded sham-controlled trial study

Mortality prediction by serum melatonin levels of patients with spontaneous intracerebral hemorrhage